A Study on the Candidate Gene Association and Interaction with Measures of UV Exposure in Pseudoexfoliation Patients from India

References

• Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317(5843):1397–1400. doi: 10.1126/science.1146554.
   PubMed Web of Science ®Google Scholar
• Pasquale LR, Jiwani AZ, Zehavi-Dorin T, Majd A, Rhee DJ, Chen T, Turalba A, Shen L, Brauner S, Grosskreutz C, et al. Solar exposure and residential geographic history in relation to exfoliation syndrome in the United States and Israel. JAMA Ophthalmol. 2014;132(12):1439–1445. doi: 10.1001/jamaophthalmol.2014.3326.
   PubMed Web of Science ®Google Scholar
• Tanito M, Kaidzu S, Takai Y, Ohira A. Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLOS One. 2012;7(11):e49680. doi: 10.1371/journal.pone.0049680.
   PubMed Web of Science ®Google Scholar
• Roedl JB, Bleich S, Reulbach U, Rejdak R, Naumann GOH, Kruse FE, Schlötzer-Schrehardt U, Kornhuber J, Jünemann AGM. Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm. 2007;114(5):571–575. doi: 10.1007/s00702-006-0598-z.
   PubMed Web of Science ®Google Scholar
• Kang JH, Loomis SJ, Wiggs JL, Willett WC, Pasquale LR. A prospective study of folate, Vitamin B 6, and Vitamin B 12 intake in relation to exfoliation glaucoma or suspected exfoliation glaucoma. JAMA Ophthalmol. 2014;132(5):549–559. doi: 10.1001/jamaophthalmol.2014.100.
   PubMed Web of Science ®Google Scholar
• Zenkel M, Hoja U, Gießl A, Berner D, Hohberger B, Weller JM, König L, Hübner L, Ostermann TA, Gusek-Schneider GC, et al. Dysregulated retinoic acid signaling in the pathogenesis of pseudoexfoliation syndrome. Int. J. Mol. Sci. 2022;23(11):5977. doi: 10.3390/ijms23115977.
   PubMed Web of Science ®Google Scholar
• Bernstein AM, Ritch R, Wolosin JM. Exfoliation syndrome: a disease of autophagy and LOXL1 proteopathy. J Glaucoma. 2018;27(Suppl 1):s44–S53. doi: 10.1097/IJG.0000000000000919.
   PubMedGoogle Scholar
• Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GOH. Role of Transforming growth factor-β1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res. 2001;73(6):765–780. doi: 10.1006/exer.2001.1084.
   PubMed Web of Science ®Google Scholar
• Roodnat AW, Callaghan B, Doyle C, Henry M, Goljanek-Whysall K, Simpson DA, Sheridan C, Atkinson SD, Willoughby CE. Genome-wide RNA sequencing of human trabecular meshwork cells treated with TGF-β1: relevance to pseudoexfoliation glaucoma. Biomolecules. 2022;12(11):1693. doi: 10.3390/biom12111693.
   PubMed Web of Science ®Google Scholar
• Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog Nucleic Acid Res Mol Biol. 2001; 70:1–32. doi: 10.1016/S0079-6603(01)70012-8.
   PubMed Web of Science ®Google Scholar
• Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003;88(4):660–672. doi: 10.1002/jcb.10413.
   PubMed Web of Science ®Google Scholar
• Lucero HA, Kagan HM. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci. 2006;63(19-20):2304–2316. doi: 10.1007/s00018-006-6149-9.
   PubMed Web of Science ®Google Scholar
• Schlötzer-Schrehardt U, Zenkel M. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res. 2019;189:107818. doi: 10.1016/j.exer.2019.107818.
   PubMed Web of Science ®Google Scholar
• Wang L, Yu Y, Fu S, Zhao W, Liu P. LOXL1 gene polymorphism with exfoliation syndrome/exfoliation glaucoma. J Glaucoma. 2016;25(1):62–94. doi: 10.1097/IJG.0000000000000128.
   PubMed Web of Science ®Google Scholar
• Founti P, Haidich A-B, Chatzikyriakidou A, Salonikiou A, Anastasopoulos E, Pappas T, Lambropoulos A, Viswanathan AC, Topouzis F. Ethnicity-based differences in the association of LOXL1 polymorphisms with pseudoexfoliation/pseudoexfoliative glaucoma: a meta-analysis. Ann Hum Genet. 2015;79(6):431–450. doi: 10.1111/ahg.12128.
   PubMed Web of Science ®Google Scholar
• Aung T, Ozaki M, Lee MC, Schlötzer-Schrehardt U, Thorleifsson G, Mizoguchi T, Igo RP, Haripriya A, Williams SE, Astakhov YS, et al. Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. Nat Genet. 2017;49(7):993–1004. doi: 10.1038/ng.3875.
   PubMed Web of Science ®Google Scholar
• Mullany S, Marshall H, Zhou T, Thomson D, Schmidt JM, Qassim A, Knight LSW, Hollitt G, Berry EC, Nguyen T, et al. RNA sequencing of lens capsular epithelium implicates novel pathways in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2022;63(3):26. doi: 10.1167/iovs.63.3.26.
   PubMed Web of Science ®Google Scholar
• Zenkel M, Krysta A, Pasutto F, Juenemann A, Kruse FE, Schlötzer-Schrehardt U. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2011;52(11):8488–8495. doi: 10.1167/iovs.11-8361.
   PubMed Web of Science ®Google Scholar
• Stein JD, Pasquale LR, Talwar N, Kim DS, Reed DM, Nan B, Kang JH, Wiggs JL, Richards JE. Geographic and climatic factors associated with exfoliation syndrome. Arch Ophthalmol. 2011;129(8):1053–1060. doi: 10.1001/archophthalmol.2011.191.
   PubMedGoogle Scholar
• Greene AG, Eivers SB, McDonnell F, Dervan EWJ, O'Brien CJ, Wallace DM. Differential Lysyl oxidase like 1 expression in pseudoexfoliation glaucoma is orchestrated via DNA methylation. Exp Eye Res. 2020;201:108349. doi: 10.1016/j.exer.2020.108349.
   PubMed Web of Science ®Google Scholar
• Schlötzer-Schrehardt U, Pasutto F, Sommer P, Hornstra I, Kruse FE, Naumann GOH, Reis A, Zenkel M. Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol. 2008;173(6):1724–1735. doi: 10.2353/ajpath.2008.080535.
   PubMed Web of Science ®Google Scholar
• Sureshkumar I, Gunalan V, Nareshkumar RN, Sripriya K, Ronnie G, Sharada R, Asokan R. Evaluating the impact of ocular UV exposure for the development for pseudoexfoliation syndrome in a South Indian population. Clin Exp Optom. 2022. Advance online publication. doi: 10.1080/08164622.2022.2134762.
   PubMed Web of Science ®Google Scholar
• Yilmaz SG, Palamar M, Onay H, Ilim O, Aykut A, Ozkinay FF, Yagci A. LOXL1 gene analysis in Turkish patients with exfoliation glaucoma. Int Ophthalmol. 2016;36(5):629–635. doi: 10.1007/s10792-016-0174-y.
   PubMed Web of Science ®Google Scholar
• Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265. doi: 10.1093/bioinformatics/bth457.
   PubMed Web of Science ®Google Scholar
• Qin ZS, Niu T, Liu JS. Partition-ligation–expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet. 2002;71(5):1242–1247. doi: 10.1086/344207.
   PubMed Web of Science ®Google Scholar
• Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics. 2007;23(8):1038–1039. doi: 10.1093/bioinformatics/btm058.
   PubMed Web of Science ®Google Scholar
• Czarnecka KH, Migdalska-Sęk M, Domańska D, Pastuszak-Lewandoska D, Dutkowska A, Kordiak J, Nawrot E, Kiszałkiewicz J, Antczak A, Brzeziańska-Lasota E. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer. Int J Oncol. 2016;49(3):1175–1184. doi: 10.3892/ijo.2016.3610.
   PubMed Web of Science ®Google Scholar
• Pastuszak-Lewandoska D, Kordiak J, Migdalska-Sęk M, Czarnecka KH, Antczak A, Górski P, Nawrot E, Kiszałkiewicz JM, Domańska D, Brzeziańska-Lasota E. Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients. Respir Res. 2015;16(1):76. doi: 10.1186/s12931-015-0230-6.
   PubMedGoogle Scholar
• de Winter JCF. Using the student’s ‘t’-test with extremely small sample sizes. Pract. Assess. Res. Evaluation. 2013;18(10):1–12.
   Google Scholar
• Debret R, Cenizo V, Aimond G, André V, Devillers M, Rouvet I, Mégarbané A, Damour O, Sommer P. Epigenetic silencing of lysyl oxidase-like-1 through dna hypermethylation in an autosomal recessive cutis laxa case. J Invest Dermatol. 2010;130(11):2594–2601. doi: 10.1038/jid.2010.186.
   PubMed Web of Science ®Google Scholar
• Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L, Kumaramanickavel G. Association of non-synonymous single nucleotide polymorphisms in the LOXL1 gene with pseudoexfoliation syndrome in India. Mol Vis. 2008;14:318–322.
   PubMed Web of Science ®Google Scholar
• Gayathri R, Coral K, Sharmila F, Sripriya S, Sripriya K, Manish P, Shantha B, Ronnie G, Vijaya L, Narayanasamy A. Correlation of aqueous humor lysyl oxidase activity with TGF-ß Levels and LOXL1 genotype in pseudoexfoliation. Curr Eye Res. 2016;41(10):1331–1338. doi: 10.3109/02713683.2015.1125505.
   PubMed Web of Science ®Google Scholar
• Pandav SS, Chakma P, Khera A, Chugh N, Gupta PC, Thattaruthody F, Seth NG, Raj S, Kaushik S, Khullar M, et al. Lack of association between lysyl oxidase-like 1 polymorphism in pseudoexfoliation syndrome and pseudoexfoliation glaucoma in North Indian population. Eur J Ophthalmol. 2019;29(4):431–436. doi: 10.1177/1120672118795405.
   PubMed Web of Science ®Google Scholar
• Dubey SK, Hejtmancik JF, Krishnadas SR, Sharmila R, Haripriya A, Sundaresan P. Lysyl oxidase–like 1 gene in the reversal of promoter risk allele in pseudoexfoliation syndrome. JAMA Ophthalmol. 2014;132(8):949. doi: 10.1001/jamaophthalmol.2014.845.
   PubMed Web of Science ®Google Scholar
• Wiggs JL, Pasquale LR. Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome. J. Glaucoma. 2014;23:S62–S63. doi: 10.1097/IJG.0000000000000124.
   PubMedGoogle Scholar
• Eliseeva N, Ponomarenko I, Reshetnikov E, Dvornyk V, Churnosov M. LOXL1 gene polymorphism candidates for exfoliation glaucoma are also associated with a risk for primary open-angle glaucoma in a Caucasian population from central Russia. Mol. Vis. 2021;27:262–269.
   PubMed Web of Science ®Google Scholar
• Zanon-Moreno V, Zanon-Moreno L, Ortega-Azorin C, Asensio-Marquez EM, Garcia-Medina JJ, Sanz P, Pinazo-Duran MD, Ordovás JM, Corella D. Genetic polymorphism related to exfoliative glaucoma is also associated with primary open-angle glaucoma risk. Clin Experiment Ophthalmol. 2015;43(1):26–30. doi: 10.1111/ceo.12367.
   PubMed Web of Science ®Google Scholar
• Pasutto F, Zenkel M, Hoja U, Berner D, Uebe S, Ferrazzi F, Schödel J, Liravi P, Ozaki M, Paoli D, et al. Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. Nat Commun. 2017;8(1):15466. doi: 10.1038/ncomms15466.
   PubMedGoogle Scholar
• Starikova D, Ponomarenko I, Reshetnikov E, Dvornyk V, Churnosov M. Novel data about association of the functionally significant polymorphisms of the MMP9 gene with exfoliation glaucoma in the caucasian population of Central Russia. Ophthalmic Res. 2021;64(3):458–464. doi: 10.1159/000512507.
   PubMed Web of Science ®Google Scholar
• Eliseeva N, Ponomarenko I, Reshetnikov E, Dvornyk V, Churnosov M. The haplotype of the CDKN2B-AS1 gene is associated with primary open-angle glaucoma and pseudoexfoliation glaucoma in the Caucasian population of Central Russia. Ophthalmic Genet. 2021;42(6):698–705. doi: 10.1080/13816810.2021.1955275.
   PubMed Web of Science ®Google Scholar
• Ponomarenko I, Reshetnikov E, Dvornyk V, Churnosov M. Functionally significant polymorphisms of the MMP9 gene are associated with primary open-angle glaucoma in the population of Russia. Eur J Ophthalmol. 2022;32(6):3208–3219. doi: 10.1177/11206721221083722.
   PubMed Web of Science ®Google Scholar
• Eliseeva NV. A replicative study of the associations of polymorphic loci of the LOXL1 and CDKN2B-AS1 genes with the development of primary open-angle glaucoma in men of the Central Black Earth Region of the Russian Federation. Res. Results Biomed. 2020;6(2):198–208. doi: 10.18413/2658-6533-2020-6-2-0-4.
   Google Scholar
• Khadzhieva MB, Kamoeva SV, Ivanova AV, Salnikova LE. Genetic factors of comorbidity of pelvic organ prolapse, stress urinary incontinence, and chronic venous insufficiency of the lower limbs in women. Russ J Genet. 2018;54(12):1479–1486. doi: 10.1134/S1022795418120049.
   Web of Science ®Google Scholar
• Abu-Amero KK, Osman EA, Dewedar AS, Schmidt S, Allingham RR, Al-Obeidan SA. Analysis of LOXL1 polymorphisms in a Saudi Arabian population with pseudoexfoliation glaucoma. Mol Vis. 2010;16:2805–2810.
   PubMed Web of Science ®Google Scholar
• Summanen P, Tönjum AM. Exfoliation syndrome among Saudis. Acta Ophthalmol. 2009;66(S184):107–111. doi: 10.1111/j.1755-3768.1988.tb02639.x.
   Google Scholar
• Pasquale LR, Kang JH, Fan B, Levkovitch-Verbin H, Wiggs JL. LOXL1 Polymorphisms: genetic biomarkers that presage environmental determinants of exfoliation syndrome. J. Glaucoma. 2018;27(Supplement 1):S20–S23. doi: 10.1097/IJG.0000000000000915.
   PubMedGoogle Scholar
• Lania L, Majello B, de Luca P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol. 1997;29(12):1313–1323. doi: 10.1016/S1357-2725(97)00094-0.
   PubMed Web of Science ®Google Scholar
• Li L, He S, Sun J-M, Davie JR. Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004;82(4):460–471. doi: 10.1139/o04-045.
   PubMed Web of Science ®Google Scholar
• Ye H, Jiang Y, Jing Q, Li D, Maimaiti T, Kasimu D, Lu Y. LOXL1 Hypermethylation in pseudoexfoliation syndrome in the Uighur population. Invest Ophthalmol Vis Sci. 2015;56(10):5838. doi: 10.1167/iovs.15-16618.
   PubMed Web of Science ®Google Scholar
• Moulin L, Cenizo V, Antu AN, André V, Pain S, Sommer P, Debret R. Methylation of LOXL1 promoter by DNMT3A in aged human skin fibroblasts. Rejuvenation Res. 2017;20(2):103–110. doi: 10.1089/rej.2016.1832.
   PubMed Web of Science ®Google Scholar
• Wu G, Guo Z, Chang X, Kim MS, Nagpal JK, Liu J, Maki JM, Kivirikko KI, Ethier SP, Trink B, et al. LOXL1 and LOXL4 are epigenetically silenced and can inhibit Ras/Extracellular signal-regulated kinase signaling pathway in human bladder cancer. Cancer Res. 2007;67(9):4123–4129. doi: 10.1158/0008-5472.CAN-07-0012.
   PubMed Web of Science ®Google Scholar
• Hauser MA, Aboobakar IF, Liu Y, Miura S, Whigham BT, Challa P, Wheeler J, Williams A, Santiago-Turla C, Qin X, et al. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus. Hum Mol Genet. 2015;24(22):6552–6563. doi: 10.1093/hmg/ddv347.
   PubMed Web of Science ®Google Scholar